← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vaxart, Inc.
San Francisco, CA
$4,965,985
Total funding
4
Grants
Funding over time
peak $1.7M · FY2007–11$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$4,965,985 · 4
By mechanism
R44$2,779,602 · 1
U01$1,246,796 · 1
R43$939,587 · 2
Investigators at Vaxart, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Enhanced Oral Vaccine Delivery Vehicle$975,540
R44 · FY2011 · AI
Enhanced Oral Vaccine Delivery Vehicle$953,135
R44 · FY2009 · AI
Enhanced Oral Vaccine Delivery Vehicle$850,927
R44 · FY2010 · AI
Mucosal Vector with TLR3 agonist for protection against VEE$631,471
U01 · FY2010 · AI
Mucosal Vector with TLR3 agonist for protection against VEE$615,325
U01 · FY2009 · AI
Enhanced Oral Vaccine Delivery Vehicle$300,000
R43 · FY2008 · AI
Enhanced Oral Vaccine Delivery Vehicle$299,082
R43 · FY2007 · AI
Recombinant Adenoviral Vector with Encoded TLR3 Ligand for Protection Against VEE$219,512
R43 · FY2008 · AI
Recombinant Adenoviral Vector with Encoded TLR3 Ligand for Protection Against VEE$120,993
R43 · FY2009 · AI